<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04828499</url>
  </required_header>
  <id_info>
    <org_study_id>WDD-hard-nucleus cataract</org_study_id>
    <nct_id>NCT04828499</nct_id>
  </id_info>
  <brief_title>To Compare the Progressive Cracking Technique and Conventional Chop Technique on Corneal Endothelial Cells in Patients With Hard Nucleus Cataract</brief_title>
  <official_title>To Compare the Progressive Cracking Technique and Conventional Chop Technique on Corneal Endothelial Cells in Patients With Hard Nucleus Cataract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yune Zhao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 60 participants at Eye Hospital of Wenzhou Medical University during&#xD;
      January,2017 to June 2021 will be enroll in our study. And dived them randomly into 2&#xD;
      groups:Progressive Cracking Technique (30 eyes) and Conventional Chop Technique (30 eyes) .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>corneal endothelial cell density</measure>
    <time_frame>up to 1 months</time_frame>
    <description>the number of corneal endothelial cells per unit area.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coefficient of variation of endothelial cells</measure>
    <time_frame>up to 1 months</time_frame>
    <description>represents the variation coefficient of cell area</description>
  </primary_outcome>
  <primary_outcome>
    <measure>percentage of hexagonal cells of the cells marked</measure>
    <time_frame>up to 1 months</time_frame>
    <description>represents the percentage of hexagon cells,the ideal value is above 50%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>central corneal thickness</measure>
    <time_frame>up to 1 months</time_frame>
    <description>thickness in micrometer</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hard Nuclear Cataract</condition>
  <condition>Corneal Endothelial Cell</condition>
  <condition>Progressive Cracking Technique</condition>
  <arm_group>
    <arm_group_label>Progressive Cracking Technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with hard nucleus cataract were treated with Progressive Cracking Technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Chop Technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with hard nucleus cataract were treated with Conventional Chop Technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Progressive Cracking Technique</intervention_name>
    <description>Performing the cataract surgery with our phaco chop-progressive cracking technique.</description>
    <arm_group_label>Progressive Cracking Technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Chop Technique</intervention_name>
    <description>Performing the cataract surgery with Conventional Chop Technique.</description>
    <arm_group_label>Conventional Chop Technique</arm_group_label>
    <other_name>stop and chop</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cataract with Grade IV~V nucleus sclerosis&#xD;
&#xD;
          -  Cataract surgery is planned&#xD;
&#xD;
          -  The operation was successful without any complications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with other diseases that affect the corneal endothelium&#xD;
&#xD;
          -  Has a history of anterior segment surgery&#xD;
&#xD;
          -  Failure to cooperate with follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dandan Wang</last_name>
    <phone>18258227706</phone>
    <email>wangdan4827716@yahoo.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eye Hospital of Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dandan Wang, MD</last_name>
      <phone>18258227706</phone>
      <email>wangdan4827716@yahoo.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 27, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Yune Zhao</investigator_full_name>
    <investigator_title>Vice president of Eye Hospital of Wenzhou Medical University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

